A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD

Neurology

Volumn 58, Issue 4, 2002, Pages 664-

  Dodel, R C ^a   Du, Y ^b   Depboylu, C ^a   Kurz, A ^c   Eastwood, B ^d   Farlow, M ^b   Oertel, W H ^a   Muller U ^e   Riemenschneider, M ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b INDIANA UNIVERSITY   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ELI LILLY AND COMPANY   (United States)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0037176812     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.4.664     Document Type: Article

References (7)

1. Cystatins in health and disease
2. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases
3. Co-deposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients
4. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
5. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease
6. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease
7. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI